Related Experiment Video

Updated: Jun 10, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.3K

Induced Necroptosis and Its Role in Cancer Immunotherapy

Ziyao Zhang1, Fangming Zhang1, Wenjing Xie2

  • 1The Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.

International Journal of Molecular Sciences
|October 16, 2024
PubMed

Insights

Necroptosis, a regulated cell death, shows promise in cancer therapy by triggering immune responses and overcoming resistance. Nanomedicines inducing necroptosis offer a new avenue for cancer immunotherapy.

Area of Science:

  • Immunology
  • Oncology
  • Biomedical Engineering

Background:

  • Necroptosis is a regulated cell death pathway activated by specific death receptors.
  • It is recognized for its potential to induce immune responses and overcome resistance to apoptosis, making it a promising cancer treatment strategy.
  • Understanding tumor necroptosis mechanisms is crucial for developing nano-biomedical treatments.

Purpose of the Study:

  • To review the signaling pathways of necroptosis, including RIPK1-RIPK3, TRIF-RIPK3, ZBP1-RIPK3, and IFNR-mediated pathways.
  • To discuss the interplay between tumor cell necroptosis and the immune microenvironment, encompassing cancer immunosurveillance and immune cells like dendritic cells (DCs), cytotoxic T cells, NK cells, and NKT cells.
  • To summarize recent advancements in nanomedicines that induce necroptosis for immunogenic cell death and cancer immunotherapy.

Main Methods:

  • Review of existing literature on necroptosis signaling pathways.
  • Analysis of the role of necroptosis in cancer immunology and immunosurveillance.
  • Summary of nanomedicine strategies targeting necroptosis for cancer treatment.

Main Results:

  • Identified four key signaling pathways mediating necroptosis.
  • Highlighted the immunogenic potential of necroptosis in cancer therapy.
  • Showcased nanomedicines designed to induce necroptosis and immunogenic cell death.

Conclusions:

  • Necroptosis is a potent therapeutic strategy in oncology due to its immunogenic properties.
  • The interaction between necroptosis and the immune system offers novel targets for cancer immunotherapy.
  • Nanomedicine-based induction of necroptosis holds significant promise for advancing cancer treatment.
Keywords:
DAMPscancer immunotherapyimmune microenvironmentimmunogenic cell deathnecroptosis

More Related Videos

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.5K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

297

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
857
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.6K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
342
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K